The absence of TREM2 can enhance Aβ pathophysiology during early AD, which can be exacerbated by decreased phagocytic Aβ clearance in later disease stages [265], TREM2 variants reduce the Aβ phagocytic ability of microglia. Here, TREM2 is linked to Alzheimer disease.